Chat with us, powered by LiveChat Research Paper Presentation With the information you gathered for your Research Paper, you will now create an intriguing visual presentation and present it to the class. | EssayAbode

Research Paper Presentation With the information you gathered for your Research Paper, you will now create an intriguing visual presentation and present it to the class.

  1. Research Paper Presentation
    • With the information you gathered for your Research Paper, you will now create an intriguing visual presentation and present it to the class.
    • Presentation should include following slides-
    • Introduction (1 slide)
    • literature review (2 slide)
    • Analysis of the literature (1slide)
    • Discussion paragraphs 1, 2, 3 (2 slide)
    • Conclusion (1slide)
    • Title page and reference list (2 slides)
    • Your presentation should be between 5-7 minutes long; practice it several times beforehand!

1

The Effects of Anti-Cancer Drugs on Cancer Outcomes-

Student Name

University

Professor

Course

Date

Part A: Introduction

The health and wellness of the world has majorly depended on the developments and advances made in healthcare treatment. Cancer happens to be among the latest in a long list of diseases which science has been front and center in addressing them. However, the success in mitigating other conditions has not necessarily been replicated when it comes to cancer. The condition has become quite adverse and this has made discovery of treatment more important. At the moment, there are various forms of treatment which are in use against different forms of cancers. While some have been quite effective in helping clients, others have led to negative outcomes. There is need for more understanding on the effectiveness of different kinds of drugs on different case scenarios. The prevalence of cancer and the role that it plays in affecting the lives of patients requires that there are better efforts towards finding more effective treatments.

Part B Review of Literature

Cancer

Cancer is a major cause of morbidity and mortality globally, accounting for 9.5 million deaths as of 2018. Thyroid Cancer is one of the most frequent endocrine malignancies, contributing to 3.4 percent of all cancers in the United States each year Indini et al. (2022). While there has been significant progress in the development of new cancer treatments and the increase in the use of anticancer drugs over the past few years, the side effects of these drugs can be severe and sometimes life-threatening. However, there is still a lack of evidence regarding their efficacy and safety. As a result, it is critical to assess the benefits and risks of these medications before hospitals use them to treat cancer patients. This literature review aims to assess the benefits and risks of anticancer medicines in patients with advanced cancer. This literature study will aid in a deeper understanding of these medications and their prospective usage in cancer care.

Similarities

Methodology

Silaghi et al. (2022) and Bachelard et al. (2021) conducted systematic reviews and meta-analyses to investigate the risks and advantages of anticancer medications in patients with advanced cancer, as well as potential causes of resistance to such treatments. Both investigations looked for clinical trials in English written between the years 2000 through 2021 and followed the PRISMA criteria. Indini et al. (2022) employed a different technique conducting a systematic review of the function of the mTOR and NAD pathways in malignancy treatment, progression, and resistance. This study searched Google Scholar, Scopus, PubMed, and Embase for English language papers published between 2000 through 2021.

Findings

Anticancer medication usage was related to a considerable risk of death in advanced cancer patients, according to Silaghi et al. (2022) and Bachelard et al. (2021). However, the authors discovered that these medications were linked to a considerable increase in the likelihood of surviving for at least a year. Furthermore, the researchers discovered that using these medications was related to a considerable increase in the likelihood of living for more than five years. Their findings differed significantly from those of Indini et al. (2022), who discovered that the mTOR and NAD paths are responsible for drug resistance in malignant cells. Furthermore, the authors discovered that these pathways might be possible targets for future treatment methods.

Recommendations

Targeted therapy is recommended by Bachelard et al. (2021), Indini et al. (2022), and Silaghi et al. (2022) as potential therapeutic choices for individuals with advanced cancer who have completed standard-of-care treatment. They also emphasize the necessity of knowing medication resistance mechanisms to design more effective targeted therapeutics. Furthermore, they underline the need for trustworthy biomarkers in guiding treatment decisions. Finally, they examine the prospects of immunotherapeutic and combinatorial treatment as resistance-busting techniques for targeted therapeutics.

Differences

Methodology

There are major discrepancies in technique between studies by Bachelard et al. (2021) and Indini et al. (2022). Bachelard et al. (2021) assessed the benefits and dangers of anticancer medicines in advanced cancer patients using a meta-analysis and systematic review. Indini et al. (2022) conducted a literature review to find the most recent guidelines, clinical and preclinical research, and novel perspectives in treating advanced, malignant RAIR-DTC. Both Bachelard (2021) and Indini et al. (2022) employed various databases and search phrases. Such databases included PubMed, Google Scholar, and Embase. Bachelard et al. (2021) explored clinical trials testing

Anti-cancer medications in adult patients with metastatic tumors, whereas Indini et al. (2022) looked for publications about DTC therapy and innovative therapeutic approaches. It is also worth mentioning that Bachelard et al. (2021) included a data meta-analysis, but Indini et al. (2022) did not; this is the most likely because Bachelard (2021) was concerned with assessing the effectiveness of anticancer medications. In contrast, Indini et al. (2022) were concerned with locating the most recent recommendations and research on the therapy of DTC.

Results

Indini et al. (2022) had different results than Silaghi et al. (2022). While Indini et al. (2022) discovered that the mTOR and NAD paths play a role in drug resistance development in malignant cells, Silaghi et al. (2022) discovered that targeted therapy is a viable therapeutic option for thyroid cancer.

Recommendations

When discussing therapy choices with advanced cancer patients, Bachelard et al. (2021) propose that adverse effects documented in clinical trials should be considered.

As prospective options for overcoming resistance, Indini et al. (2022) propose combinatorial treatment, dedifferentiation therapy, targeting alternative pathways and immunotherapy. Silaghi et al. (2022) propose targeted therapy for patients with distinguishable thyroid carcinoma who have developed resistance to radioiodine treatment. They advocate salvage treatment for patients who fail to respond to first-line Tyrosine kinase inhibitors therapy.

Part C: Analysis of Literature Review

Discussion

This discussion presents cancer, one of the major health problems today. In 2018, the cancer burden across the globe was 18.1 million new cases, with at least 9.6 million people dying from the disease. According to Meegan & O’Boyle (2022), one in six women and one in five men globally are forecasted to develop cancer at some point, with one in 11 women and one in eight men dying from cancer. The major types of cancer affecting the world with regards to the new cases of the disease are breast cancer and lung cancer, with at least 18.4 per cent (1.8 million) succumbing to lung cancer, thanks to the poor prognosis of lung cancer. These statistics show that cancer is a major health issue leading to millions of the global population annually. To minimize the number of deaths caused by cancer, such professionals as molecular biologists, chemical biologists, and medicinal chemists have endeavoured to discover and develop drugs that may be used to treat cancer. Chemotherapy has been found to be an extremely powerful tool in treating cancer, with current research focusing on developing new chemotherapy drugs. Undoubtedly, the availability and development of new and more effective oncology drugs are encouraging. The development of anticancer drugs has been challenged by the issue of drug relapse, resistance, and side effects. This is the problem that medical research needs to address if the lives of cancer patients are to be saved. Due to many types of cancer, there is no specific population that is targeted by the disease.

Mitigation

As pointed out earlier, chemotherapy is one of the most effective methods used in the treatment of cancer despite its side effects. According to Silaghi et al. (2022), chemotherapy seeks to kill cancer cells, which grow very fast. However, chemotherapy drugs tend to divide healthy cells as they destroy cancer cells. Such damage is associated with side effects such as hair loss, fatigue, and nausea. Fortunately, with the progression of cancer, science to manage and mitigate the unwarranted effects of chemotherapy has also witnessed significant growth. As pointed out earlier, one of the side effects of chemotherapy drugs is fatigue. Thus, patients should engage in regular exercise as a way of countering chemotherapy-induced fatigue. The exercise does not have to be intense, like going to the gym, but one may even take an evening walk, thus helping address the fatigue associated with chemotherapy drugs. In cases where the cancer patient experiences vomiting and nausea, it is important to take antiemetics drugs, which effectively eliminate the issue of nausea. Taking several small meals instead of large meals may help with nausea.

Recommendation

Resistance is manifested in virtually all effective anticancer drugs. Most patients portray either acquired or intrinsic resistance to chemotherapeutic treatment. Chemotherapy cannot be discounted as a recommendation to address the challenge of cancer, as it has tremendously helped save millions of lives across the globe. Indini et al. (2022) found that many cancer types tend to respond well to the “traditional” chemotherapy treatments such as antimitotic drugs, antimetabolites, topoisomerase inhibitors, intercalating drugs, and alkylating agents, although a few types of cancer can be cured completely using such treatment approaches. Due to the resistance of the cancer disease to chemotherapy treatment, this discussion also recommends using smart drug delivery systems (SSDS) to treat cancer. According to Silaghi et al. (2022), SSDS is a drug delivery system based on smart nano-carriers. In this regard, the system can deliver anticancer drugs to the specific target sites with less frequency of dosage in a more controlled manner, which tremendously reduces the side effects associated with conventional delivery systems of anticancer drugs.

Part D: Conclusion

Finding the right treatment for patients with advanced cancer is crucial in elongating their lives. There are different forms of therapy which have shown effectiveness but they also happen to have adverse effects on the patients. There is also the issue of resistance which should always be taken under consideration. For better treatment outcomes, it is essential that there is utilization of different treatment according to how they suit the patients. The different recommendations come with the discretion of ensuring that they bring about the best outcome in the patients. Further research will be helpful in establishing more effective ways of dealing with the cancer problem.

References

Indini, A., Fiorilla, I., Ponzone, L., Calautti, E., & Audrito, V. (2022). NAD/NAMPT and mTOR pathways in melanoma: Drivers of drug resistance and prospective therapeutic targets. International Journal of Molecular Sciences, 23(17), 9985. https://doi.org/10.3390/ijms23179985

Meegan, M. J., & O’Boyle, N. M. (2022). Special Issue “Anticancer Drugs 2021”. Pharmaceuticals, 15(4), 479. https://doi.org/10.3390/ph15040479

Moreau Bachelard, C., Coquan, E., du Rusquec, P., Paoletti, X., & Le Tourneau, C. (2021). Risks and benefits of anticancer drugs in advanced cancer patients: A systematic review and meta-analysis. EClinicalMedicine, 40, 101130. https://doi.org/10.1016/j.eclinm.2021.101130

Silaghi, H., Lozovanu, V., Georgescu, C. E., Pop, C., Nasui, B. A., Cătoi, A. F., & Silaghi, C. A. (2022). State of the art in the current management and future directions of targeted therapy for differentiated thyroid cancer. International Journal of Molecular Sciences, 23(7), 3470. https://doi.org/10.3390/ijms23073470

,

Welcome!! PowerPoint and

presentation skills!

Let’s go BACK in time:

Remember YOUR “why”!

WHY were Why were your topic

and your research question

important to YOU?

What SERVICE did you want to perform by conducting this research?

How can you best tell that “story,” and the “story” of what you learned?

What “story” will YOU tell about YOUR topic?

Put it in the chat bar!

First, let’s make sure your PowerPoint has IMPACT

Presentation Action

(Your presentation needs to tell YOUR “story” in a way that makes people want

to take some form of action as a result.)

Now, let’s see HOW you can tell it BEST!

1st prize

APA PowerPoint Design

What do these have in common?

H. A. T. S.

H. A. T. S.

• Headings – for easy navigation

H. A. T. S.

• Headings – for easy navigation

• Access – for finding and understanding

• Typeface – for ease of reading

H. A. T. S.

• Headings – for easy navigation

• Access – for finding and understanding

• Typeface – for ease of reading

• Space – for effective document design

H. A. T. S.

• Headings – for easy navigation

• Access – for finding and understanding

• Typeface – for ease of reading

• Space – for effective document design

Let’s take a look!

Compare the 4 following slides

They have the SAME exact words!

1. Pay attention to: Headings to promote easy navigation Access to promote the finding and understanding of information Typography to promote ease of reading and clear levels of information hierarchy Space to promote effective document design

2. Pay attention to headings to promote easy navigation, access to promote the finding and understanding of information, typography to promote ease of reading and clear levels of information hierarchy, and space to promote effective document design.

3. Pay attention to: Headings to promote easy navigation Access to promote the finding and understanding of information Typography to promote ease of reading and clear levels of information hierarchy Space to promote effective document design

4. Pay attention to:

Headings to promote easy navigation

Access to promote the finding and understanding of information

Typography to promote ease of reading and clear levels of information hierarchy

Space to promote effective document design

Below they are featured on a single slide

Which is hardest, and which is easiest to read, and WHY?

1. Pay attention to: Headings to promote easy navigation Access to promote the finding and understanding of information Typography to promote ease of reading and clear levels of information hierarchy Space to promote effective document design

3. Pay attention to: Headings to promote easy navigation Access to promote the finding and understanding of information Typography to promote ease of reading and clear levels of information hierarchy Space to promote effective document design

4. Pay attention to:

Headings to promote easy navigation

Access to promote the finding and understanding of information

Typography to promote ease of reading and clear levels of information hierarchy

Space to promote effective document design

2. Pay attention to headings to promote easy navigation, access to promote the finding and understanding of information, typography to promote ease of reading and clear levels of information hierarchy, and space to promote effective document design.

Slides are a backdrop to your words

Slides are a backdrop to your words

Your slide

Slides are a backdrop to your words

Your slide

YOU!

Slides almost NEVER need to stand alone

Slides almost NEVER need to stand alone

*yawn*

They need YOU to tell the story

GAME! Compare slides

• Look at the following 3 pairs of slides

GAME! Compare slides

• Look at the following 3 pairs of slides

• For each pair, identify the ways in which the second one is a “slam dunk” (or better)?

Our 20th President

• PDie He served as president for only 6 months, from March 4, 1881, until his assassination later that year

James A. Garfield

20th U.S. President

6-month term

3/1881 to

9/1881 (assassinated)

James A. Garfield

H.A.T.S.

Headings

Access

Typeface

Space

H.A.T.S.

Headings

Access

Typeface

Space

The Apes of Africa

• The following presentation is about the apes of Africa.

• It looks at the differences in ape behavior depending on their gender.

• It explores the cause of the reduction in ape population.

Apes of Africa

• differences in behavior by gender

• cause of reduction in population

What did you notice about the 2nd

slide in each pair?

Be “LEAN and MEAN!!!”

Be “LEAN and MEAN!!!”

• LESS isMORE!

Be “LEAN and MEAN!!!”

• LESS isMORE!

• Each word costs you…

Be “LEAN and MEAN!!!”

• LESS isMORE!

• Each word costs you !

Font sizes

Which do you think is the smallest everyone can reasonably see

44 point

40 point

36 point

32 point

28 point

24 point

20 point

A

B

C

D

E

F G

Font sizes 44 point

40 point

36 point

32 point

28 point

24 point

20 point

A

B

C

D

E

F G

Your answer may have been different!

Please do not go below this anyway!

Parallel Construction

Which of these sets of lines is parallel?

A

B

C

D

Puppies are

1. Cute 2. Frisky 3. I love them

Which is NOT parallel?

Puppies are 1. Cute 2. Frisky 3. I love them

Can you fix it?

Puppies are 1. Cute 2. Frisky 3. Lovable

Patient factors in medical care

1. Type of insurance 2. Is the doctor qualified 3. Pre-existing conditions

Which is not parallel?

Patient factors in medical care

1. Type of insurance 2. Is the doctor qualified 3. Pre-existing conditions

Can you fix it?

Patient factors in medical care

1. Type of insurance 2. Doctor qualifications 3. Pre-existing conditions

Develop YOUR PowerPoint to tell YOUR story!

Workshop!

Time to check

Time to check 1. Few words per slide, any art or graphics are relevant, and professional. (slides are a backdrop to what you say, not substituting for what you say)

Time to check 1. Few words per slide, any art or graphics are relevant, and professional. (slides are a backdrop to what you say, not substituting for what you say)

2. Type size is a minimum of 32 points even in graphics Font type is the same throughout the presentation

Time to check 1. Few words per slide, any art or graphics are relevant, and professional. (slides are a backdrop to what you say, not substituting for what you say)

2. Type size is a minimum of 32 points even in graphics Font type is the same throughout the presentation

3. Bulleted lists are prepared in parallel construction (see your Manual)

Time to check 1. Few words per slide, any art or graphics are relevant, and professional. (slides are a backdrop to what you say, not substituting for what you say)

2. Type size is a minimum of 32 points even in graphics Font type is the same throughout the presentation

3. Bulleted lists are prepared in parallel construction (see your Manual)

4. All slides lead to main point the presenter wants to make

Oral Presentations

Now, for the fun part!

WAIT!!! FUN???? I’m TERRIFIED of presenting!!!

Oral Presentations

Now, for the fun part!

WAIT!!! FUN???? I’m TERRIFIED of presenting!!!

Oral Presentations

Now, for the fun part!

WAIT!!! FUN???? I’m TERRIFIED of presenting!!!

Let’s see if we CAN make it fun!!

When you hear oral presentations:

What do you REALLY not like?

Make a list!

Oral Presentations What do you REALLY not like?• Reading from the slide

• No eye contact • Too quiet • No expression – all one tone • Too many “um”s • Other??

Oral Presentations What do you REALLY not like?

If you don’t like it…..

Advice:

Oral Presentations What do you REALLY not like?

Don’t do it!!!!

If you don’t like it…..

Now:

Start planning! Start the timer for yourself!

NO MORE THAN 5MINUTES!!!

Related Tags

Academic APA Assignment Business Capstone College Conclusion Course Day Discussion Double Spaced Essay English Finance General Graduate History Information Justify Literature Management Market Masters Math Minimum MLA Nursing Organizational Outline Pages Paper Presentation Questions Questionnaire Reference Response Response School Subject Slides Sources Student Support Times New Roman Title Topics Word Write Writing